Lithium Australia: Sure beats mining it – sucking millions in lithium and nickel out of old lithium batteries

Listen to ASX-listed Lithium Australia Managing Director Simon Linge talk to Matt Birney on the Bulls N’ Bears Report about Lithium Australia’s lithium battery recycling division that has hit its straps with a record quarterly profit derived from sucking lithium and nickel out of old lithium batteries.

See omnystudio.com/listener for privacy information.

Kali Metals: Why are mega-miners like Min Res and SQM hanging around this ASX junior?

Listen to ASX-listed Kali Metals Managing Director Paul Adams talk to Matt Birney on the Bulls N’ Bears Report about Kali’s multimillion-dollar WA farm in deal with one of the biggest lithium miners on the planet.

See omnystudio.com/listener for privacy information.

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals.

See omnystudio.com/listener for privacy information.

Xanadu Mines: A copper/gold PFS with biblical scale numbers!

Listen to ASX-listed Xanadu Mines Executive Chairman Colin Moorhead talk to Matt Birney on the Bulls N’ Bears Report about Xanadu’s crazy big pre-feasibility study numbers on its massive copper-gold play that has enough mineralisation to be mined for three decades.

See omnystudio.com/listener for privacy information.

Chariot Corporation: A new scalable lithium mining strategy and a doubled share price!

Listen to ASX-listed Chariot Corporation Managing Director Shanthar Pathmanathan talk to Matt Birney on the Bulls N’ Bears Report about Chariot’s new plan to just build a small-scale lithium mine that can be ramped up quickly when the lithium market takes off again.

See omnystudio.com/listener for privacy information.

Amplia Therapeutics: An oral cancer drug trial with serious results!

Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein.

See omnystudio.com/listener for privacy information.

Star Minerals: A timely pivot into uranium elephant country

Listen to ASX-listed Star Minerals Director Ashley Jones talk to Matt Birney on the Bulls N’ Bears Report about Star’s brand new uranium project that already has a solid uranium endowment and at least 11 early drill targets that look very interesting.

See omnystudio.com/listener for privacy information.

Tamboran Resources: A Gargantuan gas resource in a virgin Aussie basin

Listen to ASX-listed Tamboran Resources Managing Director Joel Riddle talk to Matt Birney on the Bulls N’ Bears Report about Tamboran’s multi-million-dollar deal to sell gas to the NT Govt from a ridiculously large Australian gas basin that is right on the verge of first gas production.

See omnystudio.com/listener for privacy information.